# Lisata Therapeutics, Inc.: Form 8-K, filed Aug 7, 2025

- Company: [Lisata Therapeutics, Inc.](/companies/lsta.md) (CIK 320017)
- Form: 8-K
- Filed: 2025-08-07
- Accepted by EDGAR: Aug 7, 2025, 16:09 ET
- Period: 2025-08-07
- Accession: 0000320017-25-000059
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/320017/000032001725000059/clbs-20250807.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/320017/000032001725000059/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/320017/000032001725000059/clbs-20250807.htm

Filed Aug 7, 2025.
Source: SEC EDGAR, the filing index for accession 0000320017-25-000059. Last ingested by Listed: Nov 14, 2026, 19:21 ET. No prices; not investment advice.
